Yi‐Tao Yu
- Molecular Biology top 1%
- RNA modifications and cancer 62
- RNA and protein synthesis mechanisms 50
- RNA Research and Splicing 50
- RNA regulation and disease 6
- RNA Interference and Gene Delivery 4
- Ubiquitin and proteasome pathways 4
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 6
- Aging top 10%
- Genetics top 10%
- Developmental Neuroscience top 10%
-
- Peptidase Inhibition and Analysis 5
- Co-authors
- John KarijolichHironori AdachiJunhui GeB Nadal-GinardPedro MoraisRoger E. BreitbartXinliang ZhaoJoan A. Steitz
- Partner nations
- United StatesChinaGermany
In The Last Decade
Yi‐Tao Yu
91 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 113
- Molecular Biology 4.0k
- Cancer Research 863
- Aging 38
- Genetics 329
- Developmental Neuroscience 42
Countries citing papers authored by Yi‐Tao Yu
This map shows the geographic impact of Yi‐Tao Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Tao Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Tao Yu more than expected).
Fields of papers citing papers by Yi‐Tao Yu
This network shows the impact of papers produced by Yi‐Tao Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Tao Yu. The network helps show where Yi‐Tao Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yi‐Tao Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 45 | |
| 6 | 2021 | 67 | |
| 7 | 2021 | 164 | |
| 8 | 2020 | 27 | |
| 9 | 2018 | 23 | |
| 10 | 2017 | 18 | |
| 11 | 2016 | 17 | |
| 12 | 2016 | 53 | |
| 13 | 2015 | 14 | |
| 14 | 2014 | 108 | |
| 15 | 2013 | 211 | |
| 16 | 2012 | 23 | |
| 17 | 2010 | 153 | |
| 18 | 2008 | 33 | |
| 19 | 2007 | 3 | |
| 20 | 2006 | 4 |
About Yi‐Tao Yu
Yi‐Tao Yu is a scholar working on Molecular Biology, Aging, Developmental Neuroscience, Cancer Research and Critical Care and Intensive Care Medicine, having authored 96 papers that have together received 4.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (62 papers), RNA and protein synthesis mechanisms (50 papers), RNA Research and Splicing (50 papers), Cancer-related molecular mechanisms research (6 papers), RNA regulation and disease (6 papers), Peptidase Inhibition and Analysis (5 papers), RNA Interference and Gene Delivery (4 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Molecular Biology (4.0k citations), Cancer Research (863 citations), Aging (38 citations), Genetics (329 citations) and Developmental Neuroscience (42 citations). Yi‐Tao Yu has collaborated with scholars based in United States, China and Germany. Frequent co-authors include John Karijolich, Hironori Adachi, Junhui Ge, B Nadal-Ginard, Pedro Morais, Roger E. Breitbart, Xinliang Zhao, Joan A. Steitz, Vijak Mahdavi and Leslie Smoot. Their work appears in journals such as RNA, Molecular and Cellular Biology, The EMBO Journal, RNA Biology and Methods in enzymology on CD-ROM/Methods in enzymology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.